Chronic myeloid leukemia (CML) is a hematological cancer that is predominantly caused by BCR-ABL translocations and for which targeted therapies have revolutionized cancer treatment18. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.